Dupilumab and Blood Eosinophilia: A Disease‐Specific Phenomenon?

Documenti analoghi

• The Role of Biologics in Reducing Mucous Plug Burden in Asthma
  di: Remo Poto, et al.
  Pubblicazione: (2025)
• Correspondence: Dupilumab‐Induced Blood Eosinophilia—Why We Need to Look Beyond the Blood
  di: Matteo Gelardi, et al.
  Pubblicazione: (2025)
• Biologics and airway remodeling in asthma: early, late, and potential preventive effects
  di: G. Varricchi, et al.
  Pubblicazione: (2024)
• Effect of the Arg16Gly β 2 ‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study
  di: Santi Nolasco, et al.
  Pubblicazione: (2025)
• The Intriguing Role of Short‐Form TSLP by Zeitvogel et al.
  di: Remo Poto, et al.
  Pubblicazione: (2025)